جست‌وجوی استاد و پژوهشگر

• Foreign Languages
• Chinese Language
• Cancer Biology
• +۲ مورد دیگر

Jianru Yang is an Adjunct Assistant Professor in the Department of Foreign Language at Virginia Commonwealth University, specializing in Chinese language instruction. This role involves teaching within the College of Humanities and Sciences framework, though the specific school affiliation is not detailed in the source text. Professor Yang's academic profile reflects dual expertise: (1) Foreign language education with a focus on Chinese linguistics and pedagogy, and (2) Cutting-edge biomedical research in cancer biology and immunology. Their interdisciplinary research explores: Molecular mechanisms of cancer progression (e.g., MDA-9/Syntenin signaling, tumor microenvironment) Immunotherapeutic strategies (vaccine development, immune checkpoint modulation) Metabolic reprogramming in disease (fatty acid oxidation, sphingolipid pathways) Inflammation regulation (NLRP3 inflammasome, scavenger receptors) Analysis of 15 recent publications (2022-2024) reveals consistent focus on translational oncology, with themes spanning cancer immunotherapy development, metastasis biology, immune cell dysfunction, and therapeutic target validation across multiple cancer types (lung, prostate, melanoma, breast). Research methodologies frequently integrate molecular biology, preclinical models, and immunometabolism.

Edoardo Sozziمشاهده پروفایل

پژوهشگر ارشد

• Neuroscience
• Neurobiology
• Stem Cell Research
• +۶ مورد دیگر

Edoardo Sozzi is a Visiting Research Fellow and PhD student at Lund University's Faculty of Medicine, specializing in the Developmental and Regenerative Neurobiology group under Prof. Malin Parmar. He earned a BSc in Biotechnology (2018) and a dual MSc in Neuroscience (2020) from the University of Pisa and Scuola Normale Superiore, Italy. His research focuses on the development, functionality, and diversity of human dopaminergic neurons using 3D cell culture systems like brain organoids and xenograft models, with heavy reliance on single-cell RNA sequencing. His work intersects neuroscience, developmental biology, and regenerative medicine, targeting neurodegenerative disorders such as Parkinson's disease. Key publication trends include innovations in organoid technology , single-cell transcriptomics , and WNT signaling modulation . He has contributed to 11 scientific outputs , including a 2025 doctoral thesis, peer-reviewed articles in Nature Methods and Development , and a 2023 Horizon Europe grant (OpenMIND project) for opto-electronic neural modeling in neurodegenerative diseases. Sozzi actively participates in academic events, organizing conferences like Neuroscience Day 2024 and UniStem Day 2024 , and serves as a presenter in multidisciplinary initiatives (MultiPark). His work aligns with UN Sustainable Development Goals for Medical and Health Sciences and Neurosciences .

Alex Whiteمشاهده پروفایل

پژوهشگر ارشد

• Photonics
• Quantum Optics
• Electrical Engineering
• +۳ مورد دیگر

Alex White is a Research Fellow at Stanford University, currently working in the Deisseroth Lab. He earned his undergraduate degree in electrical engineering from Caltech (2019) and a PhD in electrical engineering from Stanford (2024). His research bridges optics, computation, and neuroscience to develop novel photonic tools for understanding whole-brain connectivity. Education: Caltech (BS 2019), Stanford (PhD 2024) Current affiliation: Deisseroth Lab, Stanford University Expertise: Inverse-designed photonic systems, quantum science, and neural data analysis Alex's work spans classical and quantum photonics, with a focus on inverse design methodologies for nanophotonic devices. His publications highlight innovations in on-chip laser stabilization, nonlinear optical isolators, and structured light applications for high-dimensional quantum communication. Recent research explores photonic crystal microresonator integration for brain connectivity analysis. While not explicitly detailed in the text, Alex's scholarly output demonstrates deep engagement with emerging subfields including: On-chip quantum communication protocols Photonic inverse design optimization Nonlinear optical isolation techniques 3D lensless imaging systems CRISPRi screening methodologies Photonic crystal cavity dynamics

Adelheid (Heidi) Lempradlمشاهده پروفایل

استادیار

• Epigenetics
• Metabolism
• Intergenerational Inheritance
• +۳ مورد دیگر

Dr. Adelheid (Heidi) Lempradl is an Assistant Professor in the Department of Metabolism and Nutritional Programming at Van Andel Institute, where she leads a research laboratory focused on understanding how parental metabolic states are transmitted across generations. Her work bridges epigenetics, metabolism, and developmental biology to uncover mechanisms of intergenerational inheritance. Dr. Lempradl's research explores how environmental factors like diet impact future generations through epigenetic mechanisms. Her laboratory investigates molecular pathways that underlie phenotype transmission across generations, with particular focus on how parental nutrition affects offspring health. She was the first to demonstrate that paternal diet reprograms offspring metabolism in Drosophila and identified the first epigenetic signature of obesity conserved across species. Her recent publications reveal trends in early embryonic metabolism, transgenerational epigenetic inheritance, metabolic programming, and the identification of distinct cell subtypes relevant to metabolic diseases. Her work spans from fundamental mechanisms in Drosophila models to mammalian systems and human relevance. 2002 DOC-fFORTE Ph.D. Fellowship from the Austrian Academy of Sciences Nominated for the Helmholtz Young Investigator Diabetes (HelDi) Award in 2018 Keynote address at SETAC/iEOS Joint Topic Meeting on Environmental and (Eco) Toxicological Omics and Epigenetics Dr. Lempradl mentors several postdoctoral fellows and graduate students including Alix Booms, Eduardo Perez-Mojica, April Rickle, Ellen Stirtz, and Krittika Sudhakar. Her laboratory works closely with the Van Andel Institute Graduate School and collaborates extensively with researchers at Max Planck Institute. The Lempradl Laboratory is part of Van Andel Institute's comprehensive metabolism and nutrition research program launched in 2018.

Zhi Tanمشاهده پروفایل

استادیار

• Drug Discovery
• Computational Chemistry
• Cancer Therapeutics
• +۳ مورد دیگر

Zhi Tan, M.D., Ph.D., is an Assistant Professor at Baylor College of Medicine, holding joint appointments in the Department of Pharmacology and Chemical Biology and the Center for Drug Discovery. He is affiliated with the Jan and Dan Duncan Neurological Research Institute in Houston, TX. Dr. Tan earned his MD from Wuhan University (2012) and a PhD from the University of Texas MD Anderson Cancer Center and UT Health Graduate School of Biomedical Sciences (2018). His research focuses on leveraging computational chemistry, bioinformatics, and chemical biology to develop novel therapeutics for diseases such as cancers. Key areas include small molecule inhibitors for targeted therapy, computational algorithms for drug discovery, and RNA-protein interaction modulators. His lab has secured significant funding, including a $2M CPRIT First Time Tenure Track Faculty Award (2022–2027) to advance drug discovery efforts. Notable publications highlight breakthroughs in noncoding RNA modulation, SARS-CoV-2 protease inhibitors, and epigenetic drivers of glioblastoma progression. Lab members include Assistant Professor Fei Yuan, and collaborations span diverse disciplines from informatics to synthetic chemistry. The lab’s translational focus bridges basic science and clinical applications, with ongoing projects targeting enzyme activation pathways and male contraception mechanisms.

Shuk-Mei Hoمشاهده پروفایل

استاد

• Environmental Epigenetics
• Prostate Cancer
• Endocrine Disruptors
• +۳ مورد دیگر

Shuk-Mei Ho is a Professor in the Department of Pharmacology and Toxicology at the University of Arkansas for Medical Sciences (UAMS), part of the College of Medicine. She holds a B.Sc. (1974) and Ph.D. (1978) from the University of Hong Kong, followed by postdoctoral training at Boston University (1980). Her research focuses on environmental epigenetics, prostate cancer, and endocrine-disrupting chemicals like bisphenol A (BPA). She has led or collaborated on NIH-funded studies investigating the effects of environmental exposures on cancer risk, developmental programming, and immune function. Dr. Ho’s work spans environmental health, cancer biology, and toxicology. Key projects include examining how metals and estrogens influence prostate cancer progression, the epigenetic impacts of prenatal chemical exposure, and the role of nuclear receptors in liver cancer. She has also studied the health effects of e-waste pollution and open burn pit exposure. Her interdisciplinary collaborations involve biostatisticians, biochemists, and clinicians, reflecting her translational research approach. Her publications highlight contributions to understanding how environmental chemicals reprogram epigenetic landscapes, particularly in developmental contexts. Recent work emphasizes maternal-fetal health, metabolomic changes linked to pollutants, and sex-specific vulnerabilities to asthma and birth outcomes. Dr. Ho’s grants include VA Merit Awards and NIH funding for projects on estrogen therapies, epigenomic effects of environmental estrogens, and prostate cancer stem cells. Education: B.Sc., University of Hong Kong, 1974 Ph.D., University of Hong Kong, 1978 Postdoc, Boston University, 1980 Key Research Themes: Environmental Epigenetics Prostate Cancer Mechanisms Endocrine Disruptor Toxicity Developmental Origins of Disease Notable Grants: VA Merit Award: Metal-induced prostate cancer risk NIH R01: Prostaglandin biosynthesis in lymphangioleiomyomatosis NIH Center for Environmental Genetics (PI)

Shyam Prabhakarمشاهده پروفایل

استاد پژوهشی

• Genomics
• Transcriptional Regulation
• Bioinformatics
• +۷ مورد دیگر

Shyam Prabhakar is a Senior Group Leader and Associate Director at the A*STAR Genome Institute of Singapore (GIS). His research focuses on gene-regulatory mechanisms in human diseases using high-throughput omics technologies and computational methods. Key roles include leading the Laboratory of Systems Biology and Data Analytics, and contributing to initiatives like the Human Cell Atlas (HCA) and Asian Immune Diversity Atlas (AIDA). Research Interests: Transcriptional regulation in cancer, autism, and immune disorders Single-cell and spatial omics data analysis Development of algorithms for genomic data interpretation Major Achievements: First single-cell transcriptomic analysis of colorectal tumors (Nature Genetics 2017) Landmark studies on histone acetylation in autism (Cell 2016) and tuberculosis immunity (Nature Microbiology 2022) Key contributions to spatial omics tools like BANKSY (Nature Genetics 2024) Labs/Teams: Prabhakar Lab, Spatial and Single Cell Systems Platform, Human Cell Atlas initiatives.

Yi Chenمشاهده پروفایل

استادیار

• Economics
• Information Economics
• Game Theory
• +۳ مورد دیگر

Yi Chen is an Assistant Professor of Economics at Cornell University's College of Arts and Sciences. He holds a Ph.D. in Economics from Yale University (2018), with earlier degrees including a B.S. and B.A. from Peking University (2009), and multiple advanced degrees from Yale (2016-2018). His research focuses on information economics, integrating theoretical and applied approaches to principal-agent problems, dynamic games, and information design. He also explores interdisciplinary topics in molecular biology and genetics, including RNA-mediated epigenetic regulation and chromatin architecture. His work spans economics and biological sciences, with notable contributions to understanding Polycomb repressive complex 2 (PRC2) function in stem cells, RNA-dependent chromatin interactions, and CRISPR-based mutagenesis techniques. Recent research highlights include studies on H3K27 methylation dynamics and the role of noncoding RNAs in transcriptional regulation. While no formal advising roles or grants are listed, his research intersects economics theory with molecular mechanisms, reflecting a unique interdisciplinary perspective. No specific lab affiliations or teams are mentioned in the provided materials.

Stephanie Moonمشاهده پروفایل

استادیار

• mRNA Function
• RNA-Protein Granules
• Translation Regulation
• +۶ مورد دیگر

Stephanie Moon, Ph.D., is an Assistant Professor in the Department of Human Genetics at the University of Michigan Medical School. Her primary research focuses on mRNA function, localization, and RNA-protein granules, particularly in the context of cellular stress responses and neurodegenerative diseases. Her lab investigates mechanisms of translation regulation under stress and the role of VCP mutations in diseases like ALS and frontotemporal dementia. Education: Postdoctoral Fellow at Howard Hughes Medical Institute and University of Colorado-Boulder (2014-2019); Ph.D. in Pathology from Colorado State University (2009-2014); B.S. in Chemistry and Biology from Fort Lewis College (2003-2008). Research interests include stress granule dynamics, integrated stress response signaling, and translational control in health and disease. Her work is supported by grants from NIGMS/NIH, the Paul F. Glenn Center, and the Chan Zuckerberg Initiative Neurodegeneration Challenge Network. Lab team includes postdoctoral fellows, graduate students, and undergraduate researchers. Key collaborations involve the Neuroscience Graduate Program and the Michigan-Israel partnership. Current projects explore therapeutic strategies for VCP-related disorders and genetic diseases linked to stress response pathways. Publications span 65 peer-reviewed articles, with recent focus on ribosome-mRNA interactions, stress granule assembly, and disease mechanisms. Awards and honors are pending explicit mentions in the provided texts.

• Bioinformatics
• Computational Genomics
• Transcriptional Regulation
• +۴ مورد دیگر

Zhiping Weng is a Professor and Chair of the Department of Genomics and Computational Biology at the University of Massachusetts Chan Medical School. She holds the Li Weibo Chair in Biomedical Research and is affiliated with the T.H. Chan School of Medicine and Morningside Graduate School of Biomedical Sciences. Her research focuses on computational biology, genomics, and systems biology, with a particular emphasis on understanding gene regulation, epigenomics, and small RNA biology. Dr. Weng earned her B.S. in Electrical Engineering from the University of Science and Technology of China (1992) and her Ph.D. in Biomedical Engineering from Boston University (1997). She joined UMass Chan Medical School in 2008 to establish the Program in Bioinformatics and Integrative Biology. Her research integrates computational methods with high-throughput genomics data to study transcriptional regulation, protein interactions, and small RNA mechanisms. Key projects include developing tools for predicting transcription factor binding sites, analyzing nucleosome positioning, and modeling protein complexes. Her lab also explores the role of piRNAs and miRNAs in transposon silencing and developmental processes. Recent work includes studies on tRNA sequencing, koala retrovirus evolution, and the functional annotation of regulatory elements across species. Her contributions span bioinformatics tool development (e.g., ZDOCK for protein docking) and collaborative efforts in genome-wide studies like ENCODE. Dr. Weng advises students and postdocs in computational biology and collaborates extensively on epigenetic and systems biology projects. Her lab is part of the broader genomic research community at UMass Chan, contributing to advancements in personalized medicine and functional genomics.

Seena Ajitمشاهده پروفایل

استاد

• Molecular mechanisms of pain
• Epigenetic regulation
• MicroRNA expression and regulation
• +۳ مورد دیگر

Seena Ajit, PhD, is a Professor in the Department of Pharmacology & Physiology at Drexel University College of Medicine. She leads the Ajit Lab, which focuses on epigenetic mechanisms of pain, particularly involving microRNAs and extracellular vesicles. Her research investigates biomarkers for chronic pain conditions like complex regional pain syndrome (CRPS) and the role of exosomes in intercellular communication. Education: PhD from Rutgers University. Research Interests: Molecular mechanisms of neuropathic and inflammatory pain, epigenetic regulation, miRNA expression, and biomarker discovery. The lab explores exosome-mediated signaling and the role of noncoding RNAs such as XIST in pain pathogenesis, with a focus on sex-based differences. Awards: Mary DeWitt Pettit Fellowship (2017), Faculty Mentoring Award (2016), Rita Allen Foundation Grant (2010–2013). Advising & Grants: Supervises PhD and MS students in pharmacology, physiology, and related disciplines. Collaborates on grants including a CURE Formula Grant with Dr. Mortensen on sex differences in neuropathic pain. Mentored numerous students, many of whom hold academic or industry roles. Labs & Teams: Director of the Ajit Lab, part of the Pharmacology & Physiology Department. Active in the Drexel University College of Medicine’s research community, contributing to drug discovery and translational pain research initiatives.

Sean Limesandمشاهده پروفایل

استاد

• Fetal Development
• Endocrinology
• Animal Physiology
• +۳ مورد دیگر

Sean Limesand, PhD is a Professor at the University of Arizona's School of Animal Sciences & Comparative Biomedical Sciences. His research focuses on fetal development, endocrine adaptations, and metabolic programming in animal models, particularly sheep and goats. Key areas include fetal growth restriction (FGR), placental insufficiency, and the long-term impacts of in utero stressors like hypoxia, heat, and maternal infections. His work integrates molecular biology (e.g., transcriptomics), cellular physiology (e.g., β-cell function), and whole-animal studies. Notable contributions include identifying dysregulated pathways in growth-restricted fetal tissues, characterizing mitochondrial adaptations in FGR, and exploring therapeutic interventions (e.g., oxygen/glucose therapy in ovine models). Research also addresses environmental challenges like maternal heat stress and its effects on lactation/placental function, as well as SARS-CoV-2's impact on maternal-neonatal outcomes. His studies often involve interdisciplinary approaches, combining omics technologies with physiological measurements to understand developmental origins of health and disease. Current studies investigate single-cell transcriptomics of SS-cells in FGR, epigenetic modifications in thermotolerant ewes, and molecular mechanisms linking fetal programming to adult metabolic disorders. These efforts aim to translate findings into clinical strategies for managing growth-restricted infants and improving livestock resilience.

Tae Hoon Kimمشاهده پروفایل

دانشیار

• Functional Genomics
• Epigenetics
• Transcriptional Regulation
• +۶ مورد دیگر

Tae Hoon Kim is an Associate Professor in the Department of Biological Sciences at The University of Texas at Dallas (UTD), where he also served as Department Head from 2019 to 2023. His research focuses on functional genomics, epigenetics, and transcriptional regulation, with applications to cancer biology, innate immunity, and chronic pain. He holds a Ph.D. in Biochemistry from Harvard University, an M.A. in Molecular and Cellular Biology from Harvard, and a B.A. in Biology from Reed College. His work integrates genomic and computational approaches to study nuclear processes, chromosomal organization, and disease mechanisms. Kim’s research group has pioneered studies on enhancer function, CTCF-mediated chromatin interactions, and the role of long noncoding RNAs in cancer. Notable contributions include uncovering links between metabolic pathways and oncogenesis, as well as mechanisms underlying lymphatic vascular development. His lab, the Functional Genomics Laboratory, innovates techniques like ChIP-seq and 3C-based analyses to study gene regulation at the genome scale. Kim has received prestigious awards such as the Pew-Stewart Scholar Award (2011), Sidney Kimmel Scholar Award (2008), and Rita Allen Scholar Award (2007). His work has been published in high-impact journals, including Brain , Nature , and Genome Research . Collaborations with institutions like MD Anderson Cancer Center and Baylor College of Medicine highlight his interdisciplinary approach to translational research. His current projects address chronic pain mechanisms, leveraging transcriptomic data from human dorsal root ganglia, and targeting metabolic vulnerabilities in squamous cell carcinomas. Kim’s training includes postdoctoral work at the Ludwig Institute for Cancer Research (2002–2006) and a prior faculty position at Yale University (2006–2013).

Courtney C. Babbittمشاهده پروفایل

دانشیار

• Evolutionary Genomics
• Gene Regulation
• Cis-Regulatory Elements
• +۷ مورد دیگر

Courtney C. Babbitt is an Associate Professor in the Department of Biology at the University of Massachusetts Amherst, with additional affiliation to the Commonwealth Honors College. Her research is centered in evolutionary genomics, focusing on gene regulation, cis-regulatory evolution, and phenotypic differences between humans and non-human primates. B.A., Columbia University, 1999 Ph.D., University of Chicago, 2005 Postdoctoral Training, Duke University, 2006–2013 Her research integrates computational and experimental approaches to study genome-wide changes in gene expression, noncoding RNA, and enhancer activity, particularly in neural and metabolic contexts across primates. She investigates how regulatory evolution shapes phenotypic innovation, with a focus on brain development and function. Recent publications highlight trends in primate brain gene expression, metabolic differences in neural cell types, and the functional evolution of regulatory elements. Her work frequently employs comparative genomics in human, chimpanzee, and other primates, using fibroblasts, neural progenitor cells, and brain tissues. While no personal scientific awards are listed, her students have received recognitions such as the Henry Little Award, UMass 21st Century Leadership Award, and travel awards for conference presentations, reflecting strong mentorship. Katie Rickelton – Outstanding Student Presentation, AABA 2025 Rithvik – Henry Little Award in BMB Chiruza – UMass 21st Century Leadership Award Dr. Babbitt actively advises graduate students and leads the Babbitt Lab for Evolutionary Genomics, which uses high-throughput sequencing and functional genomics to explore the genotype-to-phenotype map. The lab has secured ongoing research activity as evidenced by recent publications and student involvement. Current projects include functional testing of rapidly evolving cis-regulatory regions and comparative analyses of brain metabolism and extracellular matrix heterogeneity. The Babbitt Lab is located in Morrill Science Center III at UMass Amherst, with active research in neural cell type-specific gene expression, astrocyte activation, and evolutionary transcriptomics. The lab fosters a collaborative environment integrating bioinformatics and wet-lab techniques to address fundamental questions in evolutionary biology.

Yun Wuمشاهده پروفایل

استاد

• Cancer theranostics
• Biosensors
• Cancer biomarkers
• +۲ مورد دیگر

Professor Yun Wu is a faculty member in the Department of Biomedical Engineering at the School of Engineering and Applied Sciences, University at Buffalo. She leads the Engineered Theranostics Laboratory, focusing on nanotechnology-enabled solutions for cancer detection and treatment. Her research integrates engineering principles with biomedical applications. PhD in Chemical and Biomolecular Engineering from The Ohio State University (2009) Postdoctoral work at Ohio State's Nanoscale Science and Engineering Center (2009-2013) Assistant/Associate/Full Professor at University at Buffalo (2013-present) Yun Wu's research spans cancer theranostics through: Development of multifunctional nanoparticles for drug/gene delivery Exosome-based biosensor platforms for liquid biopsy Microfluidic methods for nanoparticle synthesis Targeted cancer therapies overcoming drug resistance Biodegradable zwitterionic polymers as PEG alternatives Surface plasmon resonance biosensors for protein/RNA detection Her 15 most recent publications demonstrate expertise in: Exosome isolation and biomarker analysis Lipoplex nanoparticle engineering Multi-drug delivery systems Photoacoustic and fluorescence imaging Pharmacokinetic modeling Clinical translation of nanotherapeutics Current research grants include: $3.1M NCI grant for Exo-PROS lung cancer detection (2022-2027) $2.4M NIBIB project on zwitterionic polymer-drug conjugates (2023-2027) $0.4M NCI grant for exosomal glycoantigen biomarkers (2022-2024) Co-investigator in $0.9M NHLBI fibrosis-on-chip system (2020-2023) Lab members include PhD, MS, and undergraduate researchers. Collaborations exist with Roswell Park Comprehensive Cancer Center and Mayo Clinic clinicians.